Related content

Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome

By Nyberg Sigrid   Bääckströöm Torbjöörn   Zingmark Elisabeth   Purdy Robert H.   Poromaa Inger Sundströöm  

Gynecological Endocrinology, Vol. 23, Iss. 5, 2007-08 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

Serum levels of prostate-specific antigen and androgens after nasal administration of a gonadotropin releasing hormone-agonist in hirsute women

By Kocak Muberra  

Gynecological Endocrinology, Vol. 18, Iss. 4, 2004-01 ,pp. : 179-185

Informa Healthcare

Access to resources Recommend Favorite

A preliminary study on reduced dose (33 or 25 μg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization–embryo transfer

By Ku Seung-Yup   Choi Young   Jee Byung   Suh Chang   Choi Young   Kim Jung   Moon Shin   Kim Seok  

Gynecological Endocrinology, Vol. 21, Iss. 4, 2005-10 ,pp. : 227-231

Informa Healthcare

Access to resources Recommend Favorite

Gonadotropin-releasing hormone-stimulated gonadotropin levels in women with premenstrual dysphoria

By Smith MJ   Schmidt PJ   Su T-P   Rubinow DR  

Gynecological Endocrinology, Vol. 19, Iss. 6, 2004-12 ,pp. : 335-343

Informa Healthcare

Access to resources Recommend Favorite

Effects of metformin administration on plasma gonadotropin levels in women with infertility, with an in vitro study of the direct effects on the pituitary gonadotrophs

By Oride Aki   Kanasaki Haruhiko   Purwana Indri   Miyazaki Kohji  

Pituitary, Vol. 13, Iss. 3, 2010-09 ,pp. : 236-241

Springer Publishing Company

Access to resources Recommend Favorite